CLEVELAND, July 22, 2013 /PRNewswire/ --
DATATRAK International, Inc. (OTCQX: DTRK), a leader
in developing cloud-based, unified eClinical® technologies
and delivering related services for the clinical trials industry,
today announced CROS NT joined the DATATRAK
Connect™ Program. CROS NT is an international Contract
Research Organization (CRO) with 21 years of experience in
biometrics.
(Logo:
http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)
Paolo Morelli, CEO and President,
said, "As CROS NT continues to grow, it is becoming increasingly
important to offer a broader technology portfolio to our customer
base. DATATRAK provides leading-edge technology,
coupled with excellent customer service. As such they are a natural
fit with our business, and I am pleased we have been able to expand
our technology offering through the Partner Program."
"We are pleased to welcome CROS NT into the
DATATRAK Connect™ Partner Program," stated
Laurence P. Birch,
DATATRAK's Chairman of the Board and CEO. "Our
DATATRAK ONE™ technology offering will help
facilitate their efforts to create a center of excellence for
clinical trial data."
The DATATRAK Connect™ Partner Program is a
collaboration between synergic companies to accelerate the drug
development process. The program allows for extended service
offerings to cover all areas of the drug development process with
the goal of reducing study costs and furthering business
development objectives.
Join DATATRAK Thought Leaders:
LinkedIn
SlideShare
The DATATRAK Blog
Facebook
Tweet: CROS NT is new DATATRAK Connect™
Partner http://bit.ly/1dOK1Jd
About CROS NT
In its 21st year, CROS NT is an international Contract
Research Organization (CRO) specialized in clinical data services.
With over 800 studies completed in a variety of therapeutic areas
and indications, CROS NT has remained focused on biometrics
including statistical consultancy, programming and analysis,
clinical data management, medical writing, pharmacovigilance and
life science technology solutions. We collect, integrate and
analyze data from various sources and use processes and technology
to ensure excellent project governance, reporting and traceability.
Visit http://www.crosnt.com/ for more information.
About DATATRAK
DATATRAK International is a worldwide technology and
services company delivering unified eClinical® solutions and
related services for the clinical trials industry.
DATATRAK built its multi-component, comprehensive
solution on a single, unified platform and expanded this concept to
include services delivery via DATATRAK's Clinical and
Consulting Services group. The Company delivers a complete
portfolio of software products designed to accelerate the reporting
of clinical research data from sites to sponsors and ultimately
regulatory authorities, faster and more efficiently than loosely
integrated technologies. The DATATRAK ONE™
software solution, deployed worldwide through an ASP or Enterprise
Transfer offering, supports Phase I – Phase IV drug and device
studies in multiple languages throughout the world.
DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information,
visit http://www.datatrak.net.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements are made based on
management's expectations, assumptions, estimates and current
beliefs concerning the operations, future results and prospects of
the Company and are subject to uncertainties and factors which are
difficult to predict and, in many instances, are beyond the control
of the Company, and which could cause actual results to differ
materially from those contemplated in these forward-looking
statements. For a list of certain factors that may cause actual
results to differ materially from those contemplated in these
forward looking statements, please see the Company's report filed
with the OTCQX Market on May 15, 2013
announcing its results for the first quarter of 2013. The Company
undertakes no obligation to update publicly or revise any
forward-looking statement whether as a result of new information,
future events or otherwise.
SOURCE DATATRAK International, Inc.